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Abstract 
The aim of this study is to compare the current state of lesion identification, the BI-RADS classification and the 
contrast-enhancement behavior at 7T and 3T breast MRI in the same patient group. Twenty-seven patients with thirty 
suspicious lesions were selected for this prospective study and underwent both 7T and 3T MRI. All examinations were 
rated by two radiologists (R1 and R2) independently on image quality, lesion identification and BI-RADS classification. 
We assessed sensitivity, specificity, NPV and PPV, observer agreement, lesion sizes, and contrast-enhancement-to-
noise ratios (CENRs) of mass lesions. Fifteen of seventeen histopathological proven malignant lesions were detected 
at both field strengths. Image quality of the dynamic series was good at 7T, and excellent at 3T (P = 0.001 for R1 and 
P = 0.88 for R2). R1 found higher rates of specificity, NPV and PPV at 7T when compared to 3T, while R2 found the 
same results for sensitivity, specificity, NPV and PPV for both field strengths. The observers showed excellent agree-
ment for BI-RADS categories at 7T (κ = 0.86) and 3T (κ = 0.93). CENRs were higher at 7T (P = 0.015). Lesion sizes were 
bigger at 7T according to R2 (P = 0.039). Our comparison study shows that 7T MRI allows BI-RADS conform analysis. 
Technical improvements, such as acquisition of T2w sequences and adjustment of B1+ field inhomogeneity, are still 
necessary to allow clinical use of 7T breast MRI.
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Background
Dynamic contrast-enhanced magnetic resonance 
imaging (DCE-MRI) of the breast has become a well-
established imaging method for detection of breast car-
cinomas, and an increased use of 1.5 tesla (T) and 3T 
DCE-MRI systems has been observed over the past dec-
ades. Compared to conventional mammography and 
ultrasound, DCE-MRI is more accurate in detecting mul-
tifocal, multicentric and contralateral disease, in assess-
ing the response to neoadjuvant chemotherapy and in 
providing preoperative staging (Peters et al. 2008). When 
compared to 1.5T, a higher field strength (3T) showed 
to have increased signal-to-noise-ratio (SNR), higher 
spatial and temporal resolution (Rahbar et  al. 2013, 
2015). The 3T field also showed differential effects on T1 
relaxation times of non-enhancing compared to gadolin-
ium-enhancing tissue, which results in better contrast 
resolution of the enhancing lesions (Rahbar et  al. 2013, 
2015; Soher 2007). Recently, there has been a growing 
interest in investigating the potential role of 7T MRI in 
breast cancer diagnosis and management (Menezes et al. 
2014; Pinker et al. 2014; Stehouwer et al. 2013b; Umutlu 
et al. 2011). Moving to 7T not only increases SNR (Brown 
et al. 2013; Korteweg et al. 2011) (and also spatial resolu-
tion), (van de Bank et al. 2013) but also brings a greater 
spectral dispersion, significantly improving magnetic 
resonance spectroscopy (MRS) (Klomp et al. 2011). Con-
sidering these new possibilities, the focus of breast imag-
ing research at 7T is not only improving morphology 
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assessment of breast lesions, but also moving towards 
obtaining metabolic and cellular information (Klomp 
et al. 2011; Loo et al. 2011; van der Kemp 2014)
There are also drawbacks of 7T, such as a greater het-
erogeneity of the static magnetic field (B0) and of the 
applied RF field (B1+). Furthermore, breast coils had 
to be developed since none were commercially avail-
able a decade ago when 7T became available for whole-
body imaging. In literature the first attempt to perform 
DCE-MRI breast imaging at 7T was made by Umutu 
et  al. using a single loop coil, showing the complexity 
of ultra–high field breast MRI. Only moderate image 
quality was achieved when using this coil (Umutlu 
et  al. 2011). Subsequent improvements in hardware 
and imaging strategies have led to an improved image 
quality and showed that 7T breast MRI is amenable to 
BI-RADS lexicon conform analysis (Stehouwer et  al. 
2013a, b). Nowadays, the first bilateral set-ups are avail-
able, which illustrates the evolution of 7T towards clini-
cal usage (Brown et al. 2014; Gruber et al. 2014; Pinker 
et  al. 2014; Stehouwer et  al. 2013a; van der Velden 
2014). Apart from the new contrast mechanisms avail-
able at 7T, such as chemical exchange saturation trans-
fer (CEST) and 31phosphorous magnetic resonance 
spectroscopy (31P-MRS), the conventional breast MRI 
still needs to at least offer comparable imaging results to 
the current clinical standard of 3T imaging to maintain 
good medical care.
Comparisons of 7T versus breast imaging at lower field 
strengths are scarce. So far, studies with healthy volun-
teers imaged using T1-weighted (T1w) non contrast-
enhanced imaging presented similar or better results 
for 7T. The 7T images showed increased SNR, better 
fat–water contrast measures and better objective image 
quality scores (Brown et al. 2013; Umutlu et al. 2011; van 
der Velden 2014). In a patient setting, using DCE-MRI, 
comparisons between 7T and 3T fields have been made 
only in one patient case (Stehouwer et al. 2013a), and in 
one patient study (Brown et al. 2013). These papers sug-
gest that DCE-MRI at 7T is technically feasible (Stehou-
wer et al. 2013a), and it can provide a high sensitivity and 
specificity using high temporal and spatial resolution 
imaging (Brown et al. 2013).
The aim of this study is to compare the current state of 
lesion identification and BI-RADS classification at DCE-
MRI at 7T and 3T in the same patient group.
Results
Study population
Thirty breast lesions were reported in 27 patients. All 
lesions were detected on conventional imaging, and were 
classified as BI-RADS 4 (n = 21) and BI-RADS 5 (n = 9). 
The mean age was 55 years (SD 8; range 32–74 years). Of 
the 30 index lesions, 17 were histopathologically malig-
nant, and 13 were benign (Table 1).
In 8 patients the 7T scan was conducted using a uni-
lateral breast coil and in 19 using a bilateral breast coil. 
Fifteen women were postmenopausal. The remaining 11 
patients were imaged with a mean of 3.4  days between 
examinations.
Image assessment
Both observers detected, at both field strengths, 15 of 17 
malignant index. Both observers classified 11 lesions as 
mass, 2 as non-mass-like-enhancement and 2 as architec-
tural distortions without enhancement. One pure DCIS 
and one IDC were not detected at either field strength. 
The detected malignant index lesions and BI-RADS 
Table 1 Characteristics of  the 27 patients with  30 sus-
picious breast lesions detected on  conventional breast 
imaging
a Lesion size of the 15 mass lesions
Characteristics
Age (years) Mean: 55 (SD: 8, range: 32–74)
Presentation on conventional imaging
 Mass 15 (50 %)
 Calcifications 11 (37 %)
 Mass + calcifications 1 (3 %)
 Architectural distortion 1 (3 %)
 Architectural distortion + calcifications 2 (7 %)
Lesion size on conventional imaging 
(mm)
mean: 19 (SD: 9, range: 7–39)a
BI-RADS category on conventional  
imaging per patient
 4 21 (70 %)
 5 9 (30 %)
Histological type
 Malignant 17 (57 %)
  Invasive ductal carcinoma 5
  Invasive lobular carcinoma 1
  Invasive ductulolobular carcinoma 7
  Ductal carcinoma in situ with invasive 
component
2
  Ductal carcinoma in situ 2
 Non-malignant 13 (43 %)
  Columnar cell lesion 2
  Radial scar lesion 1
  Atypical ductal hyperplasia 1
  Cyst 1
  Hamartoma 1
  Fibroadenoma 2
  Apocrine metaplasia 2
  Fibrocystic changes 2
  Sclerosing adenosis 1
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descriptors are presented in Table 2. The table also illus-
trates the similarities and differences in ratings between 
field-strengths for both observers. Figure  1 shows one 
example of a patient with a malignant lesion.
All patients and identified lesions are presented in 
Table 3 (with their respective BI-RADS classification and 
histopathological results).
In 3 of the 13 non-malignant lesions, a BI-RADS 4 or 
higher was rated at one or both field strengths. In case 
number 8 (Table 3), a radial scar lesion was rated as BI-
RADS 4 or 5 by both observers at both field strengths. In 
case number 12, R1 identified a non-mass-like enhance-
ment at 3T (rated as BI-RADS 4). The same lesion was 
not identified by this observer at 7T. R2 identified a non-
mass-like enhancement at 7T (BI-RADS 4), and a mass 
lesion at 3T (BI-RADS 5). In case number 19, R1 iden-
tified a non-mass-like enhancement lesion at 7T (BI-
RADS 4), and a mass and non-mass-like enhancement 
at 3T (also rated as BI-RADS 4). R2 identified non-mass-
like enhancement at both field strengths and classified 
both as BI-RADS 3. The remaining 10 cases with proven 
benign index lesions had examinations that were cor-
rectly classified as benign at both field strengths. Figure 2 
shows an example of a benign lesion.
Table  3 also shows that a number of additional find-
ings were made independently of the index lesions. These 
findings (in italic) occurred in five cases, and were all 
classified as benign. Figure 3 shows an example of benign 
additional finding (periductal enhancement), classified as 
BI-RADS 1–3 by both observers. The final histopatholog-
ical analysis showed a cyst.
According to the first observer (R1), the mean image 
quality score was 2.14  ±  0.82 for 7T images, and 
1.37  ±  0.49 for 3T. The second observer (R2) scored 
image quality as 1.96 ± 0.65 for 7T, and 1.70 ± 0.60 for 
3T (P = 0.001 for R1, and P = 0.88 for R2). Image qual-
ity scores were also calculated considering only the scans 
performed with the bilateral coil. We had similar results: 
R1 rated the image quality of the dynamic series signif-
icantly better at 3T (P =  0.021), and R2 saw no signifi-
cant difference between fields (P = 0.132). Image quality 
scores are presented in Table 4.
Table 5 shows sensitivity, specificity, NPV and PPV at 
3T and 7T for both observers. The rates were calculated 
for the 19 patients with bilateral coil and for the total 
number of patients (27).
Inter-observer agreement for BI-RADS assess-
ment categories was excellent in both 7T (κ = 0.93 and 
P = 0.0001) and 3T (κ = 0.86 and P = 0.0001).
The 11 malignant mass lesions had a mean size of 31 mm 
at 7T MRI according to R1 (SD 18, range 16–95) and a 
mean size of 28 mm at 3T MRI (SD 23, range 10–95). For 
R2 the mean size at 7T was 28 mm (SD 16, range 15–72), 
and at 3T was 24  mm (SD 13, range 12–58). The differ-
ences between field strengths were not statistically signifi-
cant for R1 (P = 0.864), but according to R2 lesions sizes 
were significantly bigger at 7T (P = 0.039). Figure 4 shows 
a patient case in which the size of the tumor was much 
more clearly depicted at 7T when compared to 3T.
CENRs measurements of the malignant mass lesions 
showed to be significantly higher at 7T (P = 0.015) with 
a mean of 2.8 (SD 1.0, range 1.4–4.6), compared to 2.0 at 
3T (SD 0.6, range 1.2–3.4).
Discussion
The performance in this study of both 7T and 3T DCE-
MRI (using conventional imaging parameters) is con-
form literature (Peters et al. 2008). Sensitivity, specificity, 
NPV and PPV were equal at both field strengths for R2. 
However, R1 achieved higher specificity, NPV and PPV 
rates at 7T (considering both coils and only bilateral coil). 
These results could be related to the simultaneous high 
spatial and temporal resolution provided at 7T when 
compared to the resolution obtained at 3T. Our find-
ings may be somewhat limited by the small sample size, 
though similar results have previously been described. 
Gruber et al. had similar outcomes to ours. The authors 
compared bilateral DCE-MRI of the breast at 3T and 7T 
in 24 patients and the results showed higher sensitivity, 
PPV and NPV at 7T. They attributed these results to high 
temporal and spatial resolution provided at the ultra-
high magnetic field (Gruber et al. 2014).
In prospective studies, Pinker et al. and Kuhl et al. ana-
lyzed the trade-off between temporal and spatial resolu-
tion in dynamic post-contrast bilateral MR imaging of 
the breast. Both authors concluded that, at lower field 
strengths, the SNR is not sufficient to acquire images 
at higher spatial resolution, even when applying accel-
eration techniques to characterize the breast lesions 
(Kuhl et  al. 2005; Pinker et  al. 2009). Recently, van den 
Bank et al. hypothesized that the necessary gain in SNR 
could be obtained at 7T field, while acceleration could 
be obtained with high-density receiver coil arrays. Using 
a unilateral 30-channel receive-only element breast coil 
(combined with a dual-channel transmit coil) the authors 
concluded that the high density of receive coil elements 
allowed high temporal and spatial resolution DCE-MRI 
of breast at 7T, associated with less DWI distortion (van 
de Bank et al. 2013).
The ultra-high resolution imaging at 7T performed in 
our study allowed better morphological characteriza-
tions of malignant breast tumors when compared to 3T, 
as illustrated in Figs. 1 and 4. In Fig. 4 the lesions’ dimen-
sions are more clearly depicted in ultra-high resolution 
7T images when compared to 3T. At 3T, the spiculated 
lesion would be classified as a T1 (tumor is less than 
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2  cm) and at 7T it would be classified as T2 (between 
2 and 5  cm). This difference upgrades the cancer from 
stage I to stage II, which results in an impact in treatment 
and, ultimately, in prognosis.
The image quality for the dynamic series at 7T was 
overall rated good by both observers. Even though 
R1 achieved higher specificity, PPV and NPV rates at 
7T, the same observer rated the image quality of the 
dynamic series at 3T significantly better, which indi-
cates that there is still room for improvement. Cur-
rent technical developments, such as dynamic B0 field 
monitoring and correction (Boer et  al. 2012), and RF 
pulses designed to compensate the linear decreasing 
B1+  field(van Kalleveen et  al. 2015) may improve the 
image quality at 7T. As an example, Boer et al. developed 
a simple field probe that proved to be useful to monitor 
temporal B0  field  variations. The acquired temporal B0 
field information could drive a dynamic module to cor-
rect the B0 magnetic field in real time (Boer et al. 2012). 
In a recent study, van Kalleveen et al. were able to com-
pensate the inhomogeneous B1+ field (while keeping the 
specific absorption rate  low) by applying tilt optimized 
flip uniformity  RF  pulses to the  breast  surface  coil (van 
Kalleveen et al. 2015).
Brown et  al. performed two studies in healthy vol-
unteers, and the results showed equal image quality for 
non-contrast-enhanced T1w imaging at 7T and 3T MRI 
(Brown et  al. 2013, 2014). In these studies, SPAIR was 
used as fat suppression technique, which is less prone 
to B0 field inhomogeneities than a binomial RF pulse. 
Fig. 1 7T (a–c) and 3T (d, e) MRI images of a 67-year-old female with an invasive lobular carcinoma in her right breast. Transverse image of 2nd 
post contrast-injection series (a, d) shows an irregular mass lesion with spiculated margins (arrows) on both field strengths. Inset shows zoomed-in 
image. Ultra-high resolution 7T image of the same slice (b). The kinetic curve assessment showed an initial rapid rise and wash-out pattern in the 
delayed phase on both field strengths (c, e). Both observers rated the lesion as BI-RADS 5
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However, SPAIR is incompatible with optimal dynamic 
imaging at 7T due to specific absorption rate (SAR) 
limitations. Other fat suppression techniques (such as 
a DIXON-based method) could be investigated for 7T 
dynamic imaging (Ma 2008) since it showed promising 
results at 3T MRI and is less sensitive to B0 distortions 
(Le-Petross et al. 2010).
In vitro research showed that gadolinium based con-
trast agents are slightly less effective at 7T compared 
to 3T (Noebauer-Huhmann et  al. 2010). However, our 
results showed a higher CENRs at 7T, and Gruber 
et  al. also reported a non-significant difference in rela-
tive signal-enhancement between 3T and 7T (Gruber 
et al. 2014). It can thus be suggested that, with adequate 
T1 weighting and the high SNR available at 7T, the 
effectiveness of the contrast agent is (more than) suffi-
cient. With the higher CENRs, all invasive mass lesions 
were conspicuous at 7T.
To our knowledge this is the second cohort study to 
compare dynamic contrast-enhanced breast MRI at 7T 
and 3T. This is a relatively new subject, therefore we 
decided to present all information obtained in unilateral 
and bilateral coils. The use of a unilateral breast coil at 
7T in the first 8 patients was subsequently replaced by 
a bilateral breast coil. This transition was a step forward 
towards clinical usage. However, further improvements 
are still necessary. By including multiple receiver ele-
ments in the bilateral coil, (van der Velden 2014) imag-
ing with a high spatial and temporal resolution can be 
combined with the use of parallel imaging techniques. As 
Table 3 Identified mass and non-mass-like enhancement lesions at 7T and 3T plus BI-RADS classification and pathology 
results
Additional findings are marked in italic
Case R1-7T BI-RADS R2-7T BI-RADS R1-3T BI-RADS R2-3T BI-RADS Pathology
1 Mass 5 Mass 5 Mass 5 Mass 5 IDLC
2 Mass 5 Mass 5 Mass 5 Mass 4 IDLC
3 Mass 5 Mass + non-mass 5 Mass 5 Mass + non-mass 5 IDLC
4 Mass 5 Mass 5 Mass 5 Mass 5 IDLC
5 Mass + satellite 5 Mass 5 Mass 5 Mass 5 IDC
6 Mass 5 Mass 5 Mass 5 Mass 5 IDC
7 Mass 5 Mass 5 Mass 5 Mass 5 IDLC
8 Mass 4 Mass 4 Mass 4 Mass 5 Radial scar lesion
9 Mass + satellite 5 Mass + non-mass 5 Mass + non-mass 5 Mass 5 IDLC
10 No lesion 1 No lesion 2 No lesion 1 No lesion 2 Apocrine metaplasia
11 No lesion 3 Non-mass 2 Non-mass 3 Non-mass 3 Cyst
12 Mass 3 Non-mass 4 Non-mass 4 Mass 5 Fibrocystic changes
13 No lesion 2 No lesion 2 No lesion 1 No lesion 2 DCIS
14 Non-mass 4 Non-mass 5 Non-mass 4 Non-mass 5 DCIS + invasive 
component
15 No lesion 1 No lesion 2 Non-mass 3 No lesion 2 Hamartoma
16 Mass 2 Mass 2× 3 No lesion 2 Mass 2× 3 Apocrine metaplasia
17 Mass 2× + non-
mass
3 Mass 2× 2 2× Mass 3 Mass 2× 3 Fibrocystic 
changes +  
fibroadenoma
18 Mass + non-mass 5 Mass 5 2× Mass 5 Mass 5 ILC
19 Non-mass 4 Non-mass 3 Mass + non-mass 4 Non-mass 2× 3 Columnar cell lesion
20 No lesion 1 No lesion 2 No lesion 2 No lesion 2 Columnar cell 
lesion + ADH
21 No lesion 2 no lesion 2 No lesion 2 No lesion 2 Sclerosing adenosis
22 Non-mass 4 Non-mass 4 Non-mass 4 Non-mass 4 DCIS + invasive 
component
23 Mass 5 Mass 5 Mass 5 Mass 5 DCIS
24 No lesion 2 No lesion 2 No lesion 2 No lesion 2 IDC









4 IDC + IDLC
27 No lesion 2 No lesion 2 No lesion 2 No lesion 2 Fibroadenoma
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mentioned previously, the feasibility of the implementa-
tion of a multiple receiver array has been shown by van 
den Bank et al. using a unilateral breast coil (van de Bank 
et al. 2013) and recently by Brown et al. in a bilateral set-
up (Brown et al. 2013, 2014).
One limitation of our study is that T2w images were not 
acquired at 7T (and neither was in previous 7T breast MRI 
studies) (Brown et al. 2013; Gruber et al. 2014; Stehouwer 
et al. 2013a, b, 2014). Due to the use of multiple refocus-
ing pulses, T2w sequences based in turbo spin echo have 
significant B1+  problems. Moreover, the association of 
the same multiple refocusing pulses and inversion recov-
ery increases the SAR substantially (which is already close 
to the SAR limit at 3T). Fat-suppressed T2w sequences 
also have severe limitations (Gruber et  al. 2014; Stehou-
wer et  al. 2013a, b). Although the latest update of the 
BI-RADS lexicon recommends to include T2w imaging 
in the breast imaging protocol, (Edwards 2013) the most 
recent published T2w data at 7T do not meet imaging 
standards, (Umutlu et al. 2011) once we lack the necessary 
homogeneous distribution of 180º flip angles. Current 
developments such as RF pulses designed to compensate 
the linear decreasing B1+ field may enable accurate T2w 
imaging at 7T (van Kalleveen et al. 2015). However, fur-
ther research and technical improvements are necessary 
(Gruber et al. 2014; van Kalleveen et al. 2015).
Another limitation is the small sample size. The first 
cohort study comparing breast MRI at 7T and 3T had a 
similar number of patients (24). Nevertheless, the pre-
sented lesions in our study encompassed a wide range of 
pathological diagnoses, including both benign and high 
risk lesions, and both in situ and invasive cancers.
Fig. 2 7T (a, b, d) and 3T (c, e) MRI images of a 65-year-old female patient. The depicted lesion in her right breast was diagnosed as fibrocystic 
changes after biopsy. Sagittal images of 2nd post contrast-injection series (a, c) show a lobular lesion (arrow) with irregular (R1 at 3T) or smooth 
margins (R1 at 7T and R2 at 3T and 7T). Inset shows zoomed-in image. Ultra-high resolution 7T image of the same slice (b). The kinetic curve assess-
ment at 7T shows a rapid rise and persistent pattern in the delayed phase (d), and at 3T a rapid rise and plateau pattern (e). R1 classified the lesion 
as BI-RADS 3, and R2 as BI-RADS 3 (3T) and BI-RADS 2 (7T)
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Conclusion
Our comparison study shows that 7T DCE breast MR 
allows BI-RADS conform analysis. However, technical 
improvements are needed (such as acquisition of T2w 
sequences and adjustment of B1+ field inhomogeneities) 
to further explore the clinical potential of 7T breast MRI.
Methods
Study population
The study population consisted of two groups. The 
first group consisted of female patients selected from 
Fig. 3 7T (a, b) and 3T (c, d) MRI results of a 47-year-old female patient with a history of inverted nipples. The biopsied index lesion in the right 
breast showed to be a cyst. Transverse image of 2nd post contrast-injection series (a, c). 7T MRI sagittal slice of high-resolution imaging (b), sagittal 
slice of 3T dynamic series at approximately the same location (d). At 7T MRI, diffuse non-mass-like enhancement was identified by R2, while R1 
identified periductal enhancement (arrow). At 3T MRI, a focal non-mass-like enhancement was identified by R1 (circle), and multiple regions of non-
mass-like enhancement were seen by R2. The observers rate the images BI-RADS 3 for 3T MRI, and BI-RADS 3 (R1) and 2 (R2) for 7T MRI
Table 4 Image quality assessment of  the 27 dynamic 
series rated by R1 and R2 at both field strengths
* <0.05 Wilcoxon matched pairs signed rank test
R1* R2
Image quality 7T 3T 7T 3T
Excellent 7 17 6 10
Good 9 10 16 15
Moderate 11 0 5 2
Poor 0 0 0 0
Non-diagnostic 0 0 0 0
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a previously initialized 7T breast MRI feasibility study 
(Stehouwer et al. 2013b). These patients also underwent 
3T MRI scan for clinical indications. The second group 
consisted of female patients who underwent both 3T 
and 7T MRI for the purpose of intra-individual compari-
son. In both groups the inclusion criteria were the same: 
women whose age was ≥18 years and with a suspicious 
breast lesion (BI-RADS 4 or 5) detected on conven-
tional imaging. Exclusion criteria for both studies were: 
age <18 years, a history of surgery or radiotherapy on the 
ipsilateral breast, a Karnofsky score  <70, pregnancy or 
lactation, and contra-indications to either MRI or admin-
istration of a gadolinium-based contrast agent.
Examinations at 7T and 3T were performed on sepa-
rate days due to the administration of the contrast 
agent. In pre-menopausal patients, MRI was performed 
between days 6 and 13 of the menstrual cycle.
Both prospective studies were approved by the Insti-
tutional Review Board of the University Medical Center 
Utrecht, the Netherlands. Written informed consent was 
obtained from all patients before participation.
Data acquisition
The 7T scans were performed on a whole-body scanner 
(Philips Healthcare, Cleveland, OH, USA). A unilateral 
two-channel (Stehouwer et al. 2013a, b; van de Bank et al. 
2013) transmit/receive breast coil (MR Coils, Drunen, 
the Netherlands) was used for the first group. A bilateral 
four-channel (Italiaander and NPKOea 2012) coil (MR 
Coils, Drunen, the Netherlands) was used for the sec-
ond group. The scan protocol included DCE (dynamic 
contrast-enhanced) imaging and an ultra-high resolu-
tion sequence. The DCE series was constructed using 
conventional imaging parameters comparable to 3T 
MRI. They consisted of seven consecutive 3D T1w gra-
dient echo (GRE) sequences with fat suppression [TR/
TE 5/2  ms, binomial nominal flip angle (FA) 15°, FOV 
160 × 160 × 160/350 (unilateral/bilateral) mm3, acquired 
resolution 1 × 1 × 2 mm3, temporal resolution 63/67 s.], 
with the administration of 0.1 mmol/kg gadobutrol (Gd, 
Bayer Schering Pharma AG, Berlin, Germany). Ultra-
high resolution imaging was performed using a T1w 
3D GRE sequence with spectrally selective adiabatic 
inversion recovery (SPAIR) fat suppression [TR/TE/TI 
7.0/2.9/120 ms, FA 12°, FOV 120 × 120 × 120/350 mm3, 
acquired resolution 0.5 mm isotropic].
For the first patient group, the 3T scans were performed 
on a whole-body scanner (Philips Healthcare, Best, the 
Netherlands), using a dedicated seven-channel receive-
only breast coil (MRI devices, Würzburg, Germany). We 
used the hospital’s clinical tumor detection and staging 
protocol. This protocol included a T2-weighted (T2w) 
sequence, DCE imaging, and a high resolution sequence. 
The dynamic series consisted of six consecutive 3D T1w 
GRE sequences with SPAIR fat suppression [TR/TE/
TI 3.1/1.17/90 ms, FA 10°, FOV 360 × 360 × 150 mm3, 
Table 5 Sensitivity, specificity, NPV and PPV at 3T and 7T for both observers (R1 and R2)
a Scans performed using both coils
b Scans performed using only the bilateral coil
Sensitivity R1 unilateral + bilateral coil (n = 27)a NPV
Specificity PPV
3T 88 % (CI 0.62–0.98) 77 % (CI 0.46–0.94) 83 % (CI 0.58–0.96) 83 % (CI 0.51–0.97)
7T 88 % (CI 0.62–0.98) 85 % (CI 0.54–0.97) 88 % (CI 0.62–0.98) 85 % (CI 0.54–0.97)
Sensitivity R1 bilateral coil (n = 19)b NPV
Specificity PPV
3T 80 % (CI 0.44–0.96) 83 % (CI 0.51–0.97) 80 % (CI 0.44–0.96) 83 % (CI 0.51–0.97)
7T 80 % (CI 0.44–0.96) 92 % (CI 0.60–0.99) 89 % (CI 0.51–0.99) 85 % (CI 0.54–0.97)
Sensitivity R2 unilateral + bilateral coil (n = 27)a NPV
Specificity PPV
3T 88 % (CI 0.62–0.98) 85 % (CI 0.54–0.97) 88 % (CI 0.62–0.98) 85 % (CI 0.54–0.97)
7T 88 % (CI 0.62–0.98) 85 % (CI 0.54–0.97) 88 % (CI 0.62–0.98) 85 % (CI 0.54–0.97)
Sensitivity R2 bilateral coil (n = 19)b NPV
Specificity PPV
3T 80 % (CI 0.44–0.96) 92 % (CI 0.6–0.99) 89 % (CI 0.51–0.99) 85 % (CI 0.54–0.97)
7T 80 % (CI 0.44–0.96) 92 % (CI 0.6–0.99) 89 % (CI 0.51–0.99) 85 % (CI 0.54–0.97)
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acquired resolution 1.1 × 1.1 × 2.4 mm3, temporal res-
olution 60 s], and with the administration of 0.1 mmol/
kg gadobutrol. High resolution imaging was per-
formed directly following the dynamic series [TR/TE/TI 
4.5/1.67/90 ms, FA 10°, FOV 360 × 380 × 180, acquired 
resolution 0.65  ×  0.65  ×  2.00  mm3]. For the second 
patient group the protocol remained the same, except 
for the 3T dynamic series that was updated to obtain an 
acquired resolution of 0.9 × 0.92 × 1.80 mm3. Therefore, 
the previous high resolution sequence was discarded.
Image analysis
Two observers (R1 and R2) independently rated all exam-
inations. R1 was a breast radiologist with 8 years of expe-
rience in breast MRI, and R2 a radiologist with 3 years of 
experience. Both observers were blinded for the histo-
pathological results.
We performed imaging analysis with Aegis breast soft-
ware (Hologic Inc. MA), which enabled the observers 
to assess kinetic curve information and to use a color-
coded overlay showing the different levels of initial and 
late enhancement. For the first group (with unilateral 
7T images), the breast of interest was pointed out to the 
observers when assessing the 3T examination (for fair 
comparison).
First, image quality was rated for the dynamic series on 
a 5-point scale based on the following:
1. Excellent: no or hardly perceivable signal intensity 
variations across the field of view, i.e. homogeneous 
B1+ field, no or only mild artifacts, homogeneous fat 
suppression, and high visual SNR.
2. Good: mild heterogeneity changes in signal inten-
sity across the field of view, e.g. mild gradual signal 
decrease from nipple towards chest wall, mild arti-
facts, mild inhomogeneity in fat suppression and 
high visual SNR.
Fig. 4 7T (a) and 3T (b) images of a 52-year-old female patient diagnosed with a ductal carcinoma in her right breast. The morphological charac-
teristics, the size and the borders of the lesion are more clearly depicted in ultra-high resolution 7T image (a) when compared to 3T images (b). This 
variation in tumor size has an impact in both staging and treatment of breast tumors. Both observers agreed on the sizes of the lesion
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3. Moderate: moderate B1+  inhomogeneity and/or 
moderate presence of artifacts and/or moderate 
inhomogeneous fat suppression and a high visual 
SNR.
4. Poor: insufficient signal intensity homogeneity, with 
substantial signal intensity variations across the field 
of view and/or substantial image degradation due to 
artifacts, substantial inhomogeneity of fat suppres-
sion and/or a low visual SNR.
5. Non-diagnostic: insufficient quality for diagno-
sis because of insufficient signal homogeneity or a 
complete loss of signal intensity in parts of the FOV 
owing to severe artifacts, severe inhomogeneity of fat 
suppression and/or poor visual SNR.
Second, all identified lesions were classified according 
to the first edition of the BI-RADS lexicon (2003) as pro-
posed by the American College of Radiology (Molleran 
and Mahoney 2010). The maximal diameter of the identi-
fied mass lesions was measured.
Lastly, contrast-enhancement-to-noise ratios 
(CENRs) were calculated for mass lesions. Calculations 
were conducted by comparing the ratio of the signal 
intensity of the lesions and the standard deviation of the 
signal in a homogenous area of tissue adjacent to the 
lesion. This comparison was made between the pre and 
post-contrast administration images (Stehouwer et  al. 
2013a), resulting in a measurement that showed the 
lesion conspicuity.
Statistics
Analyses were performed on a per examination basis. 
Image quality scores of both field strengths were com-
pared using the Wilcoxon matched pairs signed rank test. 
Sensitivity, specificity, negative predictive value (NPV), 
and positive predictive value (PPV) with 95 % confidence 
intervals (CI) were calculated using dichotomized clas-
sification scores (lesions classified as BI-RADS 1–3 were 
considered benign, and the ones classified as 4–5 were 
considered malignant). The same scores were used to cal-
culate inter-reader agreement of BI-RADS classification 
assessed with κ statistics. Histopathology was the refer-
ence standard. Sizes of malignant masses and CENRs 
were compared between field strengths using Wilcoxon 
matched pairs signed rank test. All analyses were per-
formed using SPSS 20.0 (IBM Corp., NY, USA).
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